347 related articles for article (PubMed ID: 15040586)
21. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
[TBL] [Abstract][Full Text] [Related]
22. Complement inhibition keeps mothers calm and avoids fetal rejection.
Girardi G
Immunol Invest; 2008; 37(5):645-59. PubMed ID: 18716942
[TBL] [Abstract][Full Text] [Related]
23. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
Oppermann M; Götze O
Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
[TBL] [Abstract][Full Text] [Related]
24. C5a receptor antagonists for the treatment of inflammation.
Sumichika H
Curr Opin Investig Drugs; 2004 May; 5(5):505-10. PubMed ID: 15202723
[TBL] [Abstract][Full Text] [Related]
25. Complement component 5a (C5a).
Manthey HD; Woodruff TM; Taylor SM; Monk PN
Int J Biochem Cell Biol; 2009 Nov; 41(11):2114-7. PubMed ID: 19464229
[TBL] [Abstract][Full Text] [Related]
26. The harmful role of c5a on innate immunity in sepsis.
Ward PA
J Innate Immun; 2010; 2(5):439-45. PubMed ID: 20588003
[TBL] [Abstract][Full Text] [Related]
27. Novel strategies for the treatment of sepsis.
Riedemann NC; Guo RF; Ward PA
Nat Med; 2003 May; 9(5):517-24. PubMed ID: 12724763
[TBL] [Abstract][Full Text] [Related]
28. Protective effects of C5a blockade in sepsis.
Czermak BJ; Sarma V; Pierson CL; Warner RL; Huber-Lang M; Bless NM; Schmal H; Friedl HP; Ward PA
Nat Med; 1999 Jul; 5(7):788-92. PubMed ID: 10395324
[TBL] [Abstract][Full Text] [Related]
29. High C5a levels are associated with increased mortality in sepsis patients--no enhancing effect by actin-free Gc-globulin.
Gressner OA; Koch A; Sanson E; Trautwein C; Tacke F
Clin Biochem; 2008 Aug; 41(12):974-80. PubMed ID: 18538666
[TBL] [Abstract][Full Text] [Related]
30. Complement dependency of cardiomyocyte release of mediators during sepsis.
Atefi G; Zetoune FS; Herron TJ; Jalife J; Bosmann M; Al-Aref R; Sarma JV; Ward PA
FASEB J; 2011 Jul; 25(7):2500-8. PubMed ID: 21478262
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
[TBL] [Abstract][Full Text] [Related]
32. Sepsis, apoptosis and complement.
Ward PA
Biochem Pharmacol; 2008 Dec; 76(11):1383-8. PubMed ID: 18848819
[TBL] [Abstract][Full Text] [Related]
33. Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a.
Finch AM; Wong AK; Paczkowski NJ; Wadi SK; Craik DJ; Fairlie DP; Taylor SM
J Med Chem; 1999 Jun; 42(11):1965-74. PubMed ID: 10354404
[TBL] [Abstract][Full Text] [Related]
34. The enigma of sepsis.
Riedemann NC; Guo RF; Ward PA
J Clin Invest; 2003 Aug; 112(4):460-7. PubMed ID: 12925683
[TBL] [Abstract][Full Text] [Related]
35. Systemic blockade of complement C5a receptors reduces lipopolysacharride-induced responses in the paraventricular nucleus and the central amygdala.
Crane JW; Buller KM
Neurosci Lett; 2007 Aug; 424(1):10-5. PubMed ID: 17703884
[TBL] [Abstract][Full Text] [Related]
36. The role of the complement system and the activation fragment C5a in the central nervous system.
Woodruff TM; Ager RR; Tenner AJ; Noakes PG; Taylor SM
Neuromolecular Med; 2010 Jun; 12(2):179-92. PubMed ID: 19763906
[TBL] [Abstract][Full Text] [Related]
37. THE IMMUNOPATHOGENESIS OF POLYMICROBIAL SEPSIS.
Zetoune FS; Ward PA
Shock; 2023 Feb; 59(2):311-317. PubMed ID: 36377404
[TBL] [Abstract][Full Text] [Related]
38. Rheumatoid arthritis and the complement system.
Okroj M; Heinegård D; Holmdahl R; Blom AM
Ann Med; 2007; 39(7):517-30. PubMed ID: 17852027
[TBL] [Abstract][Full Text] [Related]
39. Brief report: complement C5a promotes human embryonic stem cell pluripotency in the absence of FGF2.
Hawksworth OA; Coulthard LG; Taylor SM; Wolvetang EJ; Woodruff TM
Stem Cells; 2014 Dec; 32(12):3278-84. PubMed ID: 25132103
[TBL] [Abstract][Full Text] [Related]
40. Aptamers that bind to the human complement component receptor hC5aR1 interfere with hC5aR1 interaction to its hC5a ligand.
Kumar PKR
Mol Biol Rep; 2018 Oct; 45(5):851-864. PubMed ID: 29981048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
